Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J9325
    Short Description Inj talimogene laherparepvec
    Long Description Injection, talimogene laherparepvec, per 1 million plaque forming units
    Pricing indicator 51
    Coverage code C
    ASC payment group code YY
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2017-01-01
    Date Added 2017-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    55513007801 J9325 Inj talimogene laherparepvec IMLYGIC AMGEN USA, INC. 1 million PFU 1 1 1 1
    55513007901 J9325 Inj talimogene laherparepvec IMLYGIC AMGEN USA, INC. 1 million PFU 1 1 100 100
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 1 million PFU
    HCPCS/CPT Billing Units 1
    Total doses ordered
    Billing Units 1

    Drug Details

    • Talimogene laherparepvec injection is used to treat certain melanoma (a type of skin cancer) tumors that cannot be removed surgically or that came back after being treated with surgery. Talimogene laherparepvec is in a class of medications called oncolytic viruses. It is a weakened and changed form of Herpes Simplex Virus Type I (HSV-1 'cold sore virus') that works by helping to kill cancer cells.